Genomic and epigenomic evolution of acquired resistance to combination therapy in esophageal squamous cell carcinoma.

2.28), which had a lower mutational burden, and the PR patient showed a trend toward increased mutations during therapies ( Figure 3C and Supplemental Figure 3B , Kruskal-Wallis rank-sum test, P = 0.031).

also in 53,322 other papers